As of 2025-01-20, the EV/EBITDA ratio of MEI Pharma Inc (MEIP) is -0.32. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. MEIP's latest enterprise value is 12.15 mil USD. MEIP's TTM EBITDA according to its financial statements is -37.58 mil USD. Dividing these 2 quantities gives us the above MEIP EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 11.4x - 15.1x | 13.7x |
| Forward P/E multiples | 13.0x - 15.0x | 14.0x |
| Fair Price | (63.06) - 36.06 | (21.22) |
| Upside | -2298.7% - 1157.3% | -840.0% |
| Date | EV/EBITDA |
| 2025-01-17 | -0.32 |
| 2025-01-16 | -0.31 |
| 2025-01-15 | -0.31 |
| 2025-01-14 | -0.30 |
| 2025-01-13 | -0.30 |
| 2025-01-10 | -0.29 |
| 2025-01-08 | -0.29 |
| 2025-01-07 | -0.28 |
| 2025-01-06 | -0.29 |
| 2025-01-03 | -0.29 |
| 2025-01-02 | -0.27 |
| 2024-12-31 | -0.25 |
| 2024-12-30 | -0.25 |
| 2024-12-27 | -0.25 |
| 2024-12-26 | -0.24 |
| 2024-12-24 | -0.23 |
| 2024-12-23 | -0.23 |
| 2024-12-20 | -0.26 |
| 2024-12-19 | -0.25 |
| 2024-12-18 | -0.26 |
| 2024-12-17 | -0.28 |
| 2024-12-16 | -0.27 |
| 2024-12-13 | -0.29 |
| 2024-12-12 | -0.29 |
| 2024-12-11 | -0.29 |
| 2024-12-10 | -0.31 |
| 2024-12-09 | -0.31 |
| 2024-12-06 | -0.29 |
| 2024-12-05 | -0.29 |
| 2024-12-04 | -0.30 |
| 2024-12-03 | -0.31 |
| 2024-12-02 | -0.30 |
| 2024-11-29 | -0.31 |
| 2024-11-27 | -0.31 |
| 2024-11-26 | -0.32 |
| 2024-11-25 | -0.30 |
| 2024-11-22 | -0.31 |
| 2024-11-21 | -0.31 |
| 2024-11-20 | -0.31 |
| 2024-11-19 | -0.32 |
| 2024-11-18 | -0.32 |
| 2024-11-15 | -0.33 |
| 2024-11-14 | -0.35 |
| 2024-11-13 | -0.35 |
| 2024-11-12 | -0.37 |
| 2024-11-11 | -0.37 |
| 2024-11-08 | -0.35 |
| 2024-11-07 | -0.35 |
| 2024-11-06 | -0.35 |
| 2024-11-05 | -0.35 |